HB 6501 would require insurance companies to give covered persons access to at least three independent or retail pharmacies within a five-mile radius of the person’s residence when filling prescriptions. In practical terms, the bill is aimed at ensuring that insured patients have nearby pharmacy choices rather than being limited to a narrow network of preferred or designated pharmacies.
The bill is framed as a consumer-access measure and does not appear to create a new benefit or mandate coverage of additional drugs; instead, it regulates how insurers structure pharmacy access for prescription fulfillment. By setting a minimum local choice standard, it could affect pharmacy network design, insurer contracting practices, and the availability of in-network pharmacies for patients in both urban and suburban areas, with potentially greater implications in communities where pharmacy options are already limited.
Impact
If enacted, the bill would amend the general statutes governing insurance practices by imposing a pharmacy-access requirement on insurance companies. Insurers would need to ensure that covered persons have at least three independent or retail pharmacy options within five miles of their residence for prescription fills, which could require changes to pharmacy network arrangements, provider contracts, and plan administration. The practical effect would be to expand consumer access to local pharmacies and potentially reduce restrictions tied to narrow pharmacy networks.
Sentiment
There is no recorded committee transcript or vote history available for this bill, so no formal legislative debate or recorded sentiment can be identified from the provided materials. Based on the bill text alone, the measure appears consumer-oriented and likely intended to improve convenience and access for insured patients. However, without discussion or votes, it is not possible to determine whether the proposal faced support, opposition, or amendments.
Contention
No specific points of contention are documented in the provided materials. Potential areas of disagreement, if the bill were debated, would likely involve insurer concerns about network flexibility, cost, and contracting burdens versus consumer and pharmacy advocates’ interest in preserving local access and choice. The bill’s requirement of three nearby pharmacy options could also raise questions about feasibility in rural or underserved areas, but those issues are not reflected in any available transcript or vote record.